+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Acadia Pharmaceuticals Inc - logo

Acadia Pharmaceuticals is a biopharmaceutical company that focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. Its lead product candidate, NUPLAZID, has completed the Phase III pivotal trials for the treatment of Parkinson's disease, Phase II trial for the treatment of schizophrenia and Phase II study for the treatment of Alzheimer's disease. The company was founded in 1993 and is headquartered in San Diego, California.

Alzheimer's Disease - Pipeline Review, H2 2020 - Product Thumbnail Image

Alzheimer's Disease - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 1785 Pages
  • Global
From
From
Extractables and Leachables Testing Services Market, 2018-2028 - Product Thumbnail Image

Extractables and Leachables Testing Services Market, 2018-2028

  • Report
  • September 2018
  • 200 Pages
  • Global
From
Malignant Pleural Mesothelioma- Pipeline Insight, 2022 - Product Thumbnail Image

Malignant Pleural Mesothelioma- Pipeline Insight, 2022

  • Clinical Trials
  • March 2022
  • 60 Pages
  • Global
From
Markets at a Glance: Pharmaceuticals - Product Thumbnail Image

Markets at a Glance: Pharmaceuticals

  • Report
  • May 2019
  • 115 Pages
  • Global
From
Oncology Market Forecast (2020-2025) - Product Thumbnail Image

Oncology Market Forecast (2020-2025)

  • Report
  • August 2020
  • 142 Pages
  • Global
From
Psychosis Global Clinical Trials Review, H2, 2019 - Product Thumbnail Image

Psychosis Global Clinical Trials Review, H2, 2019

  • Clinical Trials
  • December 2019
  • 290 Pages
  • Global
From
From
From
Loading Indicator